Reconstitution of hTERT restores tumorigenicity in melanoma-derived c-Myc low-expressing clones

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Oncogene

• Publication date

  2002-05-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.onc.1205415PMID 12082531
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations

  2001cited by this paper
• Extra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastases

  2001cited by this paper
• Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes

  2001cited by this paper
• c-Myc down-regulation increases susceptibility to cisplatin through reactive oxygen species-mediated apoptosis in M14 human melanoma cells.

  2001influential reference
• Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis

  2000cited by this paper
• Cell biology: Risky immortalization by telomerase

  2000cited by this paper
• Cancer: New link in a web of human genes

  2000cited by this paper
• Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT).

  2000cited by this paper
• Creation of human tumour cells with defined genetic elements

  1999cited by this paper
• Increase of cisplatin sensitivity by c-myc antisense oligodeoxynucleotides in a human metastatic melanoma inherently resistant to cisplatin.

  1999cited by this paper
• Inhibition of telomerase limits the growth of human cancer cells

  1999cited by this paper
• Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation

  1999influential reference
• Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype

  1999cited by this paper
• Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death.

  1999cited by this paper
• Short Dysfunctional Telomeres Impair Tumorigenesis in the INK4aD2/3 Cancer-Prone Mouse

  1999influential reference
• Telomere shortening and apoptosis in telomerase-inhibited human tumor cells.

  1999cited by this paper
• Absence of cancer–associated changes in human fibroblasts immortalized with telomerase

  1999cited by this paper
• Direct activation of TERT transcription by c-MYC

  1999cited by this paper
• p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis.

  1999cited by this paper
• Short dysfunctional telomeres impair tumorigenesis in the INK4a(delta2/3) cancer-prone mouse.

  1999cited by this paper
• Extension of life-span by introduction of telomerase into normal human cells.

  1998cited by this paper
• Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization.

  1998cited by this paper
• Telomerase activity, cell proliferation, and cancer.

  1998cited by this paper
• Myc activates telomerase.

  1998cited by this paper
• c-myc antisense oligodeoxynucleotides enhance the efficacy of cisplatin in melanoma chemotherapy in vitro and in nude mice.

  1998cited by this paper
• Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation

  1998influential reference
• Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span.

  1998cited by this paper
• hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization.

  1997cited by this paper
• Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT

  1997cited by this paper
• Myc target genes.

  1997cited by this paper
• c-Myc transactivation of LDH-A: implications for tumor metabolism and growth.

  1997cited by this paper
• Telomerase catalytic subunit homologs from fission yeast and human.

  1997cited by this paper
• Myc represses transcription of the growth arrest gene gas1.

  1997cited by this paper
• A survey of telomerase activity in human cancer.

  1997cited by this paper
• Telomerase activity in human leukemic cell lines is inhibited by antisense pentadecadeoxynucleotides targeted against c-myc mRNA.

  1997cited by this paper
• Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice.

  1996influential reference
• Telomerase and cancer: revisiting the telomere hypothesis.

  1996cited by this paper
• Cdc25 cell-cycle phosphatase as a target of c-myc

  1996cited by this paper
• Myc‐Max heterodimers activate a DEAD box gene and interact with multiple E box‐related sites in vivo.

  1996cited by this paper
• A link between c-Myc-mediated transcriptional repression and neoplastic transformation.

  1996cited by this paper
• A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins.

  1995cited by this paper
• Correlating telomerase activity levels with human neuroblastoma outcomes

  1995influential reference
• The ornithine decarboxylase gene is a transcriptional target of c-Myc.

  1993cited by this paper
• The MYC protein activates transcription of the alpha‐prothymosin gene.

  1991cited by this paper
• Telomeres shorten during ageing of human fibroblasts

  1990cited by this paper
• Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo.

  1987cited by this paper
• The myc oncogene: its role in transformation and differentiation.

  1986cited by this paper
• Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes

  1983cited by this paper
• Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells.

  1982cited by this paper

• Dyads of G-quadruplex ligands triggering DNA damage response and tumour cell growth inhibition at sub-nM concentration.

  2019cites this paper
• The downregulation of c-Myc and its target gene hTERT is associated with the antiproliferative effects of baicalin on HL-60 cells.

  2017cites this paper
• SIRT6 interacts with TRF2 and promotes its degradation in response to DNA damage

  2016cites this paper
• Exploring the chemical space of G-quadruplex binders: discovery of a novel chemotype targeting the human telomeric sequence.

  2013cites this paper
• The Human Melanoma Side Population Displays Molecular and Functional Characteristics of Enriched Chemoresistance and Tumorigenesis

  2013cites this paper
• Aromatic Core Extension in the Series of N‐Cyclic Bay‐Substituted Perylene G‐Quadruplex Ligands: Increased Telomere Damage, Antitumor Activity, and Strong Selectivity for Neoplastic over Healthy Cells

  2012cites this paper
• Shooting for selective druglike G-quadruplex binders: evidence for telomeric DNA damage and tumor cell death.

  2012cites this paper
• Receptor‐Based Virtual Screening and Biological Characterization of Human Apurinic/Apyrimidinic Endonuclease (Ape1) Inhibitors

  2012cites this paper
• N-cyclic bay-substituted perylene G-quadruplex ligands have selective antiproliferative effects on cancer cells and induce telomere damage.

  2011cites this paper
• PARP1 is activated at telomeres upon G4 stabilization: possible target for telomere-based therapy

  2010influential citation
• Stabilization of quadruplex DNA perturbs telomere replication leading to the activation of an ATR-dependent ATM signaling pathway

  2009cites this paper
• Telomere damage induced by the G-quadruplex ligand RHPS4 has an antitumor effect.

  2007cites this paper
• Diagnostics, prognostic and therapeutic exploitation of telomeres and telomerase in leukemias.

  2006cites this paper
• Role of Phosphoramidate Antisense in Specific Inhibition of K562 Leukemic Cell Line

  2006cites this paper
• TRF2 inhibition triggers apoptosis and reduces tumourigenicity of human melanoma cells.

  2006cites this paper
• Multiple interference of the human papillomavirus-16 E7 oncoprotein with the functional role of the metastasis suppressor Nm23-H1 protein

  2006cites this paper
• Telomeres and telomerase: Pharmacological targets for new anticancer strategies?

  2006cites this paper
• Involvement of hTERT in apoptosis induced by interference with Bcl-2 expression and function

  2005cites this paper
• Telomerase activity in colorectal carcinoma and its correlation with expression of c-myc

  2005cites this paper
• Biological Activity of the G-Quadruplex Ligand RHPS4 (3,11-Difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate) Is Associated with Telomere Capping Alteration

  2004influential citation
• Biological Activity of the G-quadruplex Ligand RHPS4 is Associated with Telomere Capping Alteration

  2004cites this paper
• Telomerase as a new target for the treatment of hormone-refractory prostate cancer.

  2004cites this paper
• Antisense oligonucleotide targeting at the initiator of hTERT arrests growth of hepatoma cells.

  2004cites this paper
• Telomerase activity, apoptosis and cell cycle progression in ataxia telangiectasia lymphocytes expressing TCL1

  2003cites this paper
• Inhibition of telomerase increases resistance of melanoma cells to temozolomide, but not to temozolomide combined with poly (adp-ribose) polymerase inhibitor.

  2003cites this paper
• The future of antisense therapy: combination with anticancer treatments

  2003cites this paper
• Telomere dysfunction increases cisplatin and ecteinascidin-743 sensitivity of melanoma cells.

  2003cites this paper
• Expression of telomerase hTERT in human non-small cell lung cancer and its correlation with c-myc gene.

  2003cites this paper
• Inhibition of c-Myc Oncoprotein Limits the Growth of Human Melanoma Cells by Inducing Cellular Crisis*

  2003cites this paper
• Che-1 affects cell growth by interfering with the recruitment of HDAC1 by Rb.

  2002cites this paper
• Glutathione Influences c-Myc-induced Apoptosis in M14 Human Melanoma Cells*

  2002cites this paper
• Anti-Aging Medicine LiteratureWatch

  2002cites this paper